SAGENT PHARMACEUTICALS COMPLETES $58 MIL SERIES A FINANCING.
Publication Date: 01-NOV-07
Publication Title: Biotech Financial Reports
Format: Online

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Description

Sagent Pharmaceuticals, Inc., Shaumberg, Ill., a privately- held specialty pharmaceutical company has announced the closing of a $53 million Series A financing led by Vivo Ventures. Proceeds from the financing will be used primarily to fund near-term product launches, product development activities and strategic business initiatives, including numerous development,...

Access Full Article, Compliments of Goliath


More articles from Biotech Financial Reports
FONAR REPORTS FISCAL 2007 NET LOSS OF $25.5 MILLION., November 01, 2007
ISORAY INC. REPORTS PRODUCT SALES INCREASED BY 188%.(Financial report), November 01, 2007

Looking for additional articles?
Click here to search our database of over 3 million articles.